Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%2522Glomerulosclerosis%252C+Focal+Segmental%2522&type=Subject&sort=year
/vufind/Search/Results?lookfor=%2522Glomerulosclerosis%252C+Focal+Segmental%2522&type=Subject&sort=year
Search /vufind/Search2/Results?lookfor=%2522Glomerulosclerosis%252C+Focal+Segmental%2522&type=Subject&sort=year
PubPharm (10)
1
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK). - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK). - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK).P/024/2021 - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK).P/024/2021 - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK). - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK). - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK).P/024/2021 - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK).P/024/2021 - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK).P/024/2021 - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. : A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK).P/024/2021 - EPPIK
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
10
WHO International Clinical Trials Registry Plat...
Thema
10
610
10
Medical Condition: Proteinuric glomerular disea...
10
Phase: Phase 2
10
Study Type: Interventional
6
Recruitment Status: Authorised-recruitment may ...
2
Recruitment Status: Not yet recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
4
2022
4
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...